W. Vanden Berghe

发表

T. Vanden Berghe, P. Vandenabeele, M. Lahtela-Kakkonen, 2018, The Journal of clinical investigation.

Yorick Janssens, E. Wynendaele, B. De Spiegeleer, 2019, Clinical Epigenetics.

M. Montourcy, W. Vanden Berghe, J. Van der Heyden, 2021, BMC Infectious Diseases.

W. Vanden Berghe, A. Dewaele, Nele Cox, 2008, Journal of LGBT health research.

G. Haegeman, K. De Bosscher, W. Vanden Berghe, 2006, Oncogene.

C. Pérez-Novo, X. Van Ostade, W. Vanden Berghe, 2017, Proceedings of the Nutrition Society.

G. Haegeman, E. Hooghe-Peters, K. De Bosscher, 2003, Biochemical pharmacology.

M. T. Donato, M. Gómez-Lechón, W. Vanden Berghe, 2018, The Journal of pharmacy and pharmacology.

G. Haegeman, W. Vanden Berghe, K. Heyninck, 2012, Biochemical pharmacology.

T. Vanden Berghe, B. D. De Geest, W. Vanden Berghe, 2019, European Polymer Journal.

G. Haegeman, L. Vermeulen, W. Vanden Berghe, 2006, Cancer treatment and research.

G. Haegeman, W. Vanden Berghe, T. Essawi, 2007, Journal of ethnopharmacology.

M. Laga, W. Vanden Berghe, K. Fransen, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

W. Vanden Berghe, Michael González-Durruthy, L. Alberici, 2019, Toxicology in vitro : an international journal published in association with BIBRA.

G. Haegeman, L. Vermeulen, K. De Bosscher, 2002, Ernst Schering Research Foundation workshop.

W. V. Berghe, G. Haegeman, K. De Bosscher, 2001, Molecular endocrinology.

C. Pérez-Novo, W. Vanden Berghe, Claudia Theys, 2022, Biomedicines.

P. Pauwels, E. Fransen, M. Peeters, 2018, Clinical Epigenetics.

C. Vervaet, P. Adriaensens, J. Lammens, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

K. Kabeya, S. De Wit, W. Vanden Berghe, 2015, Journal of acquired immune deficiency syndromes.

W. Vanden Berghe, Fausto Zaruma-Torres, Johana Ortíz-Ulloa, 2021, Toxicology reports.

M. Lahtela-Kakkonen, G. Haegeman, W. Vanden Berghe, 2014, Biochemical pharmacology.

P. Pauwels, E. Fransen, M. Peeters, 2018, Clinical Epigenetics.

W. Vanden Berghe, P. Van der Veken, J. Joossens, 2016, Bioorganic & medicinal chemistry letters.

M. Verhoye, A. Van der Linden, J. Balthazart, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

G. Kok, S. Dias, W. Vanden Berghe, 2016, Health promotion international.

L. Godderis, P. De Boever, G. Koppen, 2017, Basic & clinical pharmacology & toxicology.

T. Vanden Berghe, W. Vanden Berghe, R. Delgado-Hernández, 2020, Brain, behavior, & immunity - health.

C. Pérez-Novo, N. Verma, W. Vanden Berghe, 2019, Methods in molecular biology.

D. Lambrechts, V. Nelen, P. De Boever, 2018, Clinical Epigenetics.

G. Haegeman, W. Vanden Berghe, R. Hoya-Arias, 2006, Biochemical pharmacology.

G. Haegeman, C. Libert, K. De Bosscher, 2005, Proceedings of the National Academy of Sciences of the United States of America.

W. V. Berghe, G. Haegeman, L. Vermeulen, 2000, Proceedings of the National Academy of Sciences of the United States of America.

W. Fiers, W. V. Berghe, G. Haegeman, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Berghe, W. V. Berghe, G. Haegeman, 2010, Biochemical pharmacology.

G. Haegeman, M. Daha, C. van Kooten, 2005, Journal of the American Society of Nephrology : JASN.

W. Vanden Berghe, W. Van Hul, Sara Diels, 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

C. Libert, Ville Paakinaho, K. De Bosscher, 2021, EMBO reports.

G. Haegeman, L. Vermeulen, K. De Bosscher, 2003, Advances in experimental medicine and biology.

P. V. van Dam, W. Tjalma, Z. Berneman, 2020, Cancer Treatment Reviews.

G. Haegeman, D. Hadjipavlou-Litina, W. Vanden Berghe, 2015, Molecules.

G. Haegeman, L. Vermeulen, K. De Bosscher, 2009, Trends in biochemical sciences.

Colin R. Janssen, Filip Lemière, Lynn Vanhaecke, 2010, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

C. Pérez-Novo, W. Vanden Berghe, M. Cuendet, 2017, Clinical Epigenetics.

X. Van Ostade, W. Vanden Berghe, Martin Dom, 2020, RSC medicinal chemistry.

M. Rosińska, S. Dias, Anna-Marie Jones, 2018, The International journal on drug policy.

G. Haegeman, W. Vanden Berghe, S. Gerlo, 2008, Cellular signalling.

K. Laukens, L. V. Van Gaal, A. Tvarijonaviciute, 2021, Clinical epigenetics.

K. Devriendt, G. Mortier, Raoul Rooman, 2020, The Journal of clinical endocrinology and metabolism.

O. De Wever, C. Pérez-Novo, W. Vanden Berghe, 2020, Melanoma research.

Benoît Y. Michel, S. Pieraccini, M. Sironi, 2018, ACS medicinal chemistry letters.

J. Tavernier, G. Haegeman, C. Libert, 2013, Cellular and Molecular Life Sciences.

G. Haegeman, L. Vermeulen, W. Vanden Berghe, 2002, Biochemical pharmacology.

J. Vincke, W. Vanden Berghe, Nele Cox, 2010, Journal of youth and adolescence.

P. Spanoghe, P. Goethals, Wout Van Echelpoel, 2020, The Science of the total environment.

G. Haegeman, K. De Bosscher, B. Staels, 2002, Molecular endocrinology.

Archibold Mposhi, K. Faber, M. Rots, 2023, Frontiers in Nutrition.

D. Lambrechts, V. Nelen, P. De Boever, 2018, Clinical Epigenetics.

Yorick Janssens, E. Wynendaele, W. Vanden Berghe, 2019, Clinical Epigenetics.

W. Vanden Berghe, Andrea Orellana-Manzano, Erick Velastegui, 2023, Frontiers in Genetics.

P. Van Vlierberghe, W. Vanden Berghe, C. Novo, 2021, International journal of molecular sciences.

Kris Laukens, Pieter Meysman, Stefan Naulaerts, 2015, BMC Bioinformatics.

X. Van Ostade, W. Vanden Berghe, Rosario Gravier-Hernández, 2023, Advances in pharmacological and pharmaceutical sciences.

W. Vanden Berghe, R. Colebunders, I. De Ryck, 2011, Acta clinica Belgica.

A. Van der Linden, S. De Keulenaer, W. Vanden Berghe, 2016, Scientific Reports.

J. Tavernier, G. Haegeman, C. Libert, 2013, Cellular and Molecular Life Sciences.

G. Haegeman, W. Vanden Berghe, M. Ndlovu, 2010, Biochemical pharmacology.